Editorial: Efficacy and safety of CAR-T cell therapy in hematologic malignancies
Front Oncol
.
2024 Aug 19:14:1472463.
doi: 10.3389/fonc.2024.1472463.
eCollection 2024.
Authors
Marcos de Lima
1
,
Alice Di Rocco
2
,
Jose-Maria Ribera
3
Affiliations
1
Department of Medicine, The Ohio State University, Columbus, OH, United States.
2
Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
3
Department of Clinical Haematology, Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Barcelona, Spain.
PMID:
39224808
PMCID:
PMC11366614
DOI:
10.3389/fonc.2024.1472463
No abstract available
Keywords:
chimeric antigen receptor (CAR T); leukemia; lymphoma; myeloma; toxicity.
Publication types
Editorial